companydata.dkFaaborg Pharma - IP ApS: Financial statements 2025
CVR: 43517252
Faaborg Pharma - IP ApS (CVR 43517252) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 75,860 and a net result of DKK -678,796 compared with DKK -895,356 the year before. Equity amounted to DKK -2,291,658.
- Gross Profit
- 75,860 kr.
- Profit/Loss
- -678,796 kr.
- Equity
- -2,291,658 kr.
- Total Assets
- 2,133,431 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 76 t. | -679 t. | -2.3 mio. | 0 |
| 2024 | - | -248 t. | -895 t. | -1.6 mio. | 0 |
Find more companies like Faaborg Pharma - IP ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
Faaborg Pharma - IP ApS has published its annual report for 2024. Gross profit came to DKK -247,665, and the net result was DKK -895,356.
About Faaborg Pharma - IP ApS
Faaborg Pharma - IP ApS is a Danish company of the type Anpartsselskab based in Faaborg, founded in 2022. The company is registered under the industry Leasing af intellektuelle ejendomsrettigheder og lignende produkter, dog ikke ophavsretsbeskyttede værker. The management consists of Jan Knudsen. The company is owned by Faaborg Løve Produkter Holding I ApS. In 2025, the company reported a gross profit of DKK 75,860 and a net result of DKK -678,796 compared with DKK -895,356 the year before. Equity amounted to DKK -2,291,658.